Total Payments
$30,240
2024 Payments
$25,175
Companies
19
Transactions
363
Medicare Patients
703
Medicare Billing
$92,074
Payment Breakdown by Category
Other$22,790 (75.4%)
Food & Beverage$6,476 (21.4%)
Consulting$783.34 (2.6%)
Travel$78.67 (0.3%)
Education$58.55 (0.2%)
Gifts$53.32 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,790 | 15 | 75.4% |
| Food and Beverage | $6,476 | 333 | 21.4% |
| Consulting Fee | $783.34 | 2 | 2.6% |
| Travel and Lodging | $78.67 | 4 | 0.3% |
| Education | $58.55 | 5 | 0.2% |
| Gift | $53.32 | 1 | 0.2% |
| Unspecified | $0 | 3 | 0.0% |
Payments by Type
General
$30,240
360 transactions
Ownership
$0
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | $23,307 | 34 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $3,264 | 194 | $0 (2024) |
| ABBVIE INC. | $885.31 | 41 | $0 (2024) |
| Vertex Pharmaceuticals Incorporated | $783.34 | 2 | $0 (2023) |
| RedHill Biopharma Inc. | $501.36 | 23 | $0 (2024) |
| QOL Medical, LLC | $265.53 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $211.62 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $167.92 | 9 | $0 (2024) |
| GENZYME CORPORATION | $167.35 | 7 | $0 (2024) |
| Ardelyx, Inc. | $152.87 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,175 | 122 | Phathom Pharmaceuticals, Inc. ($23,307) |
| 2023 | $2,279 | 78 | Vertex Pharmaceuticals Incorporated ($783.34) |
| 2022 | $1,209 | 66 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($878.19) |
| 2021 | $1,059 | 62 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($782.51) |
| 2020 | $409.30 | 31 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($323.38) |
| 2019 | $86.52 | 3 | Braintree Laboratories, Inc. ($53.32) |
| 2018 | $22.43 | 1 | Ferring Pharmaceuticals Inc. ($22.43) |
All Payment Transactions
363 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | Cash or cash equivalent | $44.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $11.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $30.60 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | Cash or cash equivalent | $52.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | Cash or cash equivalent | $50.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $28.08 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.86 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Gastroenterology | ||||||
| 10/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 235 | 283 | $270,819 | $31,234 |
| 2022 | 6 | 237 | 253 | $295,505 | $31,348 |
| 2021 | 5 | 140 | 151 | $172,862 | $18,901 |
| 2020 | 5 | 91 | 96 | $103,572 | $10,592 |
Total Patients
703
Total Services
783
Medicare Billing
$92,074
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 94 | $23,970 | $8,281 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 42 | 59 | $22,125 | $8,174 | 36.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $28,524 | $6,666 | 23.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 35 | 36 | $106,200 | $5,122 | 4.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 40 | 40 | $90,000 | $2,992 | 3.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $28,560 | $7,390 | 25.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 48 | $18,000 | $6,845 | 38.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 43 | 43 | $126,850 | $6,535 | 5.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 43 | $10,965 | $3,971 | 36.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $14,380 | $3,649 | 25.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 41 | 43 | $96,750 | $2,957 | 3.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 42 | 42 | $23,142 | $5,618 | 24.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 34 | $12,750 | $5,162 | 40.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 23 | 23 | $67,850 | $3,351 | 4.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 24 | $6,120 | $2,597 | 42.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 27 | 28 | $63,000 | $2,172 | 3.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 22 | 22 | $11,712 | $2,876 | 24.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 22 | $8,250 | $2,561 | 31.0% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 15 | 15 | $44,250 | $2,207 | 5.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 22 | $5,610 | $2,019 | 36.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 15 | 15 | $33,750 | $927.22 | 2.7% |
About Dr. Morris Silver, MD
Dr. Morris Silver, MD is a Specialist healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871546127.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Morris Silver, MD has received a total of $30,240 in payments from pharmaceutical and medical device companies, with $25,175 received in 2024. These payments were reported across 363 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,790).
As a Medicare-enrolled provider, Silver has provided services to 703 Medicare beneficiaries, totaling 783 services with total Medicare billing of $92,074. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Beverly Hills, CA
- Active Since 05/18/2006
- Last Updated 09/19/2014
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1871546127
Products in Payments
- VOQUEZNA (Drug) $23,307
- XIFAXAN (Drug) $2,717
- Talicia (Drug) $438.15
- RINVOQ (Biological) $431.33
- TRULANCE (Drug) $391.51
- DUPIXENT (Biological) $290.85
- SKYRIZI (Biological) $194.99
- HUMIRA (Biological) $171.67
- SUCRAID (Drug) $164.86
- PLENVU (Drug) $155.45
- IBSRELA (Drug) $152.87
- ENTYVIO (Biological) $114.09
- Sucraid (Drug) $100.67
- TREMFYA (Drug) $90.93
- Linzess (Drug) $81.09
- STELARA (Biological) $74.72
- CLENPIQ (Drug) $58.94
- CREON (Drug) $57.95
- SUPREP BOWEL PREP (Drug) $53.32
- REBYOTA (Biological) $48.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Beverly Hills
Dr. Norman Lepor, M.d, M.D
Specialist — Payments: $3.0M
Specialist $3.0M
Dr. Michael Bush, M.d, M.D
Specialist — Payments: $614,437
Specialist $614,437
Dr. Stuart Silverman, Md, MD
Specialist — Payments: $572,532
Specialist $572,532
Dr. Suzanne Gilberg-Lenz, M.d, M.D
Specialist — Payments: $319,119
Specialist $319,119
Dr. Todd Lanman, M.d., F.a.c.s, M.D., F.A.C.S
Specialist — Payments: $308,676
Specialist $308,676
Dr. Hooman Melamed, M.d, M.D
Specialist — Payments: $202,585
Specialist $202,585